Dr. Soliman Abdel Kader Fakeeh Hospital Co. Announces an update on Dr. Soliman Abdel Kader Fakeeh Hospital Company announces the latest development regarding its signing of a binding Share Purchase Agreement to acquire 100% of the Target Company, being the issuance of non-objection of the General Authority for Competition.

Dr. Soliman Abdel Kader Fakeeh Hospital Company completed the 100% acquisition of Dr. Mohammed Bin Rashid Al Fagih & Partners Company on July 20, 2026, for a total cash consideration of SAR 1,595,625,000.
The payment includes SAR 100 million placed in an escrow account for a specified period to cover potential liabilities, with the acquisition expected to increase the company's consolidated debt levels.
The transaction increases the company’s bed capacity in Riyadh by 350 beds, creating a two-site cluster with a total of 535 beds and diversifying the patient mix to include cash and mid-tier insurance segments.
The target company will be consolidated as a wholly-owned subsidiary, with the hospital expected to generate operational efficiencies and cost synergies across the group's network.

Element List	Explanation
Introduction	With reference to the announcement made by Dr. Soliman Abdel Kader Fakeeh Hospital Company (the “Company”), which was published on the Saudi Stock Exchange's (Tadawul) website on 28/12/1447H (corresponding to 14/06/2026G) regarding the issuance of the non-objection certificate from the General Authority for Competition in respect of the acquisition of the entire share capital of Dr. Mohammed Bin Rashid Al Fagih & Partners Company (the “Target Company”) in exchange for a total cash amount of SAR 1,595,625,000 (the “Transaction”), the Company wishes to announce the completion of its acquisition of the entire share capital of the Target Company.
Previous Announcement	Dr. Soliman Abdel Kader Fakeeh Hospital Company announces the latest development regarding its signing of a binding Share Purchase Agreement to acquire 100% of the Target Company, being the issuance of non-objection of the General Authority for Competition.
Date of Previous Announcement on Saudi Exchange’s Website	2026-06-14 Corresponding to 1447-12-28
Hyperlink to the Previous Announcement on the Saudi Exchange Website	Click Here
Latest Developments Of The Announced Event	The Transaction was completed on Monday 06/02/1448H (corresponding to 20/07/2026G) with the transfer of the entire share capital of the Target Company to the Company in exchange for a total consideration of SAR 1,595,625,000 paid in cash. The consideration includes an amount of SAR 100 million placed in an escrow account for a specified period to cover any potential liabilities following completion of the Transaction.
Reasons For The Delay on The Date of The Event Previously Announced	N/A
The costs associated with the event, and if they have changed or not with indication of the reasons.	The total consideration for the acquisition of 100% of the share capital of the Target Company is a total cash amount of SAR 1,595,625,000.
Delay consequences on the Company’s financial results	N/A
Additional Information	The Transaction resulted in the Company owning 100% of the share capital of the Target Company, which will be consolidated into the Company’s group as a wholly-owned subsidiary. The Target Company is the Company’s second hospital in Riyadh and will materially expand the Company’s group presence in the city. The Transaction diversifies the Company’s payer and patient mix in Riyadh by adding exposure to Cash patients, and Network 6 / Class B insurance, complementing the Group’s existing VIP and high-tier insurance positioning. Over time, the combination is expected to generate operational efficiencies, cost synergies and enhanced revenue opportunities across Fakeeh Care’s network. The Transaction is expected to increase the Company’s consolidated debt levels reflecting both the acquisition financing and the assumption of the Target Company’s existing net debt.. The acquisition increases the Company’s bed presence in Riyadh, combining the Target Company’s 350-bed capacity with the Company’s group existing 185-bed capacity in its existing Riyadh hospital to create a 535-bed two-site cluster in a high-density catchment area.